CoChat
Sign Up
Cited by 75

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

miR-206 inhibits metastasis-relevant traits by degrading MRTF-A in anaplastic thyroid cancer

ZHANG, WEN-LONG, LV, WEI, SUN, SUO-ZHU, WU, XI-ZHAO, ZHANG, JIAN-HUA·2015·International Journal of Oncology
DOI 10.3892/ijo.2015.2993
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/ijo.2015.2993

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 44

  1. Wang, 2002, Potentiation of serum response factor activity by a family of myocardin-related transcription factors, Proc Natl Acad Sci USA, 99, 14855, 10.1073/pnas.222561499 · DOI
  2. Miralles, 2003, Actin dynamics control SRF activity by regulation of its coactivator MAL, Cell, 113, 329, 10.1016/S0092-8674(03)00278-2 · DOI · Paper page
  3. Pipes, 2006, The myocardin family of transcriptional coactivators: Versatile regulators of cell growth, migration, and myogenesis, Genes Dev, 20, 1545, 10.1101/gad.1428006 · DOI
  4. Li, 2006, Requirement of a myocardin-related transcription factor for development of mammary myoepithelial cells, Mol Cell Biol, 26, 5797, 10.1128/MCB.00211-06 · DOI
  5. Sun, 2006, Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland function, Mol Cell Biol, 26, 5809, 10.1128/MCB.00024-06 · DOI
  6. Morita, 2007, Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling, J Cell Biol, 179, 1027, 10.1083/jcb.200708174 · DOI · Paper page
  7. Xu, 2014, MicroRNA-135b promotes proliferation, invasion and migration of osteosarcoma cells by degrading myocardin, Int J Oncol, 45, 2024, 10.3892/ijo.2014.2641 · DOI
  8. Medjkane, 2009, Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis, Nat Cell Biol, 11, 257, 10.1038/ncb1833 · DOI
  9. Lee, 1993, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, 75, 843, 10.1016/0092-8674(93)90529-Y · DOI · Paper page
  10. Pasquinelli, 2000, Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA, Nature, 408, 86, 10.1038/35040556 · DOI
  11. Reinhart, 2000, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans, Nature, 403, 901, 10.1038/35002607 · DOI
  12. Kloosterman, 2006, The diverse functions of microRNAs in animal development and disease, Dev Cell, 11, 441, 10.1016/j.devcel.2006.09.009 · DOI · Paper page
  13. Meng, 2007, MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer, Gastroenterology, 133, 647, 10.1053/j.gastro.2007.05.022 · DOI · Paper page
  14. Jovanovic, 2006, miRNAs and apoptosis: RNAs to die for, Oncogene, 25, 6176, 10.1038/sj.onc.1209912 · DOI
  15. Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702 · DOI
  16. Esquela-Kerscher, 2006, Oncomirs - microRNAs with a role in cancer, Nat Rev Cancer, 6, 259, 10.1038/nrc1840 · DOI · Paper page
  17. Calin, 2006, MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 857, 10.1038/nrc1997 · DOI
  18. Kondo, 2008, miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer, Cancer Res, 68, 5004, 10.1158/0008-5472.CAN-08-0180 · DOI
  19. Zhou, 2013, miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclin D2, Biochem Biophys Res Commun, 433, 207, 10.1016/j.bbrc.2013.02.084 · DOI
  20. Taulli, 2009, The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation, J Clin Invest, 119, 2366
  21. Zhang, 2011, Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression, Anticancer Res, 31, 3859
  22. Song, 2009, MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation, J Biol Chem, 284, 31921, 10.1074/jbc.M109.046862 · DOI
  23. Chen, 2012, Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma, Cancer Lett, 314, 41, 10.1016/j.canlet.2011.09.014 · DOI
  24. Wang, 2011, MicroRNA-206 is associated with invasion and metastasis of lung cancer, Anat Rec (Hoboken), 294, 88, 10.1002/ar.21287 · DOI
  25. Yan, 2009, MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development, J Biol Chem, 284, 29596, 10.1074/jbc.M109.020511 · DOI
  26. Zhang, 2013, miR-206 inhibits gastric cancer proliferation in part by repressing cyclin D2, Cancer Lett, 332, 94, 10.1016/j.canlet.2013.01.023 · DOI
  27. Chen, 2010, Intronic CArG box regulates cysteine-rich protein 2 expression in the adult but not in developing vasculature, Arterioscler Thromb Vasc Biol, 30, 835, 10.1161/ATVBAHA.109.197251 · DOI
  28. Liao, 2014, Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway, FEBS J, 281, 927, 10.1111/febs.12658 · DOI
  29. Kong, 2012, MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma, FEBS J, 279, 1252, 10.1111/j.1742-4658.2012.08519.x · DOI
  30. Yan, 2008, MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis, RNA, 14, 2348, 10.1261/rna.1034808 · DOI
  31. Valastyan, 2009, A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis, Cell, 137, 1032, 10.1016/j.cell.2009.03.047 · DOI
  32. Shimono, 2009, Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells, Cell, 138, 592, 10.1016/j.cell.2009.07.011 · DOI
  33. Miller, 2008, MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1, J Biol Chem, 283, 29897, 10.1074/jbc.M804612200 · DOI
  34. Yun, 2007, Negative regulation of Activin/Nodal signaling by SRF during Xenopus gastrulation, Development, 134, 769, 10.1242/dev.02778 · DOI
  35. Schratt, 2004, SRF regulates Bcl-2 expression and promotes cell survival during murine embryonic development, EMBO J, 23, 1834, 10.1038/sj.emboj.7600188 · DOI
  36. Cao, 2011, Myocardin-related transcription factor-A promoting neuronal survival against apoptosis induced by hypoxia/ischemia, Brain Res, 1385, 263, 10.1016/j.brainres.2011.02.016 · DOI
  37. Ma, 2001, Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute mega-karyoblastic leukemia, Nat Genet, 28, 220, 10.1038/90054 · DOI
  38. Mercher, 2001, Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia, Proc Natl Acad Sci USA, 98, 5776, 10.1073/pnas.101001498 · DOI
  39. Descot, 2008, OTT-MAL is a deregulated activator of serum response factor-dependent gene expression, Mol Cell Biol, 28, 6171, 10.1128/MCB.00303-08 · DOI
  40. Mercher, 2009, The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knock-in mouse model, J Clin Invest, 119, 852
  41. Sasazuki, 2002, Identification of a novel transcriptional activator, BSAC, by a functional cloning to inhibit tumor necrosis factor-induced cell death, J Biol Chem, 277, 28853, 10.1074/jbc.M203190200 · DOI
  42. Brandt, 2009, SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin, Nat Cell Biol, 11, 557, 10.1038/ncb1862 · DOI
  43. Huet, 2009, Repression of the estrogen receptor-alpha transcriptional activity by the Rho/mega-karyoblastic leukemia 1 signaling pathway, J Biol Chem, 284, 33729, 10.1074/jbc.M109.045534 · DOI
  44. Evelyn, 2007, CCG-1423: A small-molecule inhibitor of RhoA transcriptional signaling, Mol Cancer Ther, 6, 2249, 10.1158/1535-7163.MCT-06-0782 · DOI

Cited by

Sorted by citations

See all 75

Metadata

Authors
ZHANG, W.-L., LV, W., SUN, S.-Z., WU, X.-Z., & ZHANG, J.-H.
Venue
International Journal of Oncology
Publisher
Spandidos Publications
Published
2015-05-08
Volume
47
Issue
1
Pages
133-142
ISSN
  • 1019-6439
  • 1791-2423
DOI
10.3892/ijo.2015.2993
Cited by
75
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review